Global Peptide CDMO Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 111

Published Date: 03 Mar 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Peptide CDMO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Peptide CDMO market size is estimated to be worth US$ 2369.8 million in 2021 and is forecast to a readjusted size of USD 6106.7 million by 2028 with a CAGR of 14.5% during forecast period 2022-2028. Commercial accounting for % of the Peptide CDMO global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While APIs and Intermediates segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Peptide CDMO include Bachem, PolyPeptide, AmbioPharm, USV Peptides, and Thermo Fisher, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Peptide CDMO market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    APIs and Intermediates
    FDF

Market segment by Application can be divided into
    Commercial
    Academic Research

The key market players for global Peptide CDMO market are listed below:
    Bachem
    PolyPeptide
    AmbioPharm
    USV Peptides
    Thermo Fisher
    Bio Basic
    JPT
    Genscript
    Xinbang Pharma
    ScinoPharm
    SN Biopharm
    CBL
    Piramal Pharma
    CordenPharma
    CPC Scientific

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peptide CDMO product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Peptide CDMO, with price, sales, revenue and global market share of Peptide CDMO from 2019 to 2022.
Chapter 3, the Peptide CDMO competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peptide CDMO breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Peptide CDMO market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Peptide CDMO.
Chapter 13, 14, and 15, to describe Peptide CDMO sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Peptide CDMO Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Peptide CDMO Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 APIs and Intermediates
        1.2.3 FDF
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Peptide CDMO Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Commercial
        1.3.3 Academic Research
    1.4 Global Peptide CDMO Market Size & Forecast
        1.4.1 Global Peptide CDMO Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Peptide CDMO Sales in Volume (2017-2028)
        1.4.3 Global Peptide CDMO Price (2017-2028)
    1.5 Global Peptide CDMO Production Capacity Analysis
        1.5.1 Global Peptide CDMO Total Production Capacity (2017-2028)
        1.5.2 Global Peptide CDMO Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Peptide CDMO Market Drivers
        1.6.2 Peptide CDMO Market Restraints
        1.6.3 Peptide CDMO Trends Analysis

2 Manufacturers Profiles
    2.1 Bachem
        2.1.1 Bachem Details
        2.1.2 Bachem Major Business
        2.1.3 Bachem Peptide CDMO Product and Services
        2.1.4 Bachem Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 PolyPeptide
        2.2.1 PolyPeptide Details
        2.2.2 PolyPeptide Major Business
        2.2.3 PolyPeptide Peptide CDMO Product and Services
        2.2.4 PolyPeptide Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 AmbioPharm
        2.3.1 AmbioPharm Details
        2.3.2 AmbioPharm Major Business
        2.3.3 AmbioPharm Peptide CDMO Product and Services
        2.3.4 AmbioPharm Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 USV Peptides
        2.4.1 USV Peptides Details
        2.4.2 USV Peptides Major Business
        2.4.3 USV Peptides Peptide CDMO Product and Services
        2.4.4 USV Peptides Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Thermo Fisher
        2.5.1 Thermo Fisher Details
        2.5.2 Thermo Fisher Major Business
        2.5.3 Thermo Fisher Peptide CDMO Product and Services
        2.5.4 Thermo Fisher Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Bio Basic
        2.6.1 Bio Basic Details
        2.6.2 Bio Basic Major Business
        2.6.3 Bio Basic Peptide CDMO Product and Services
        2.6.4 Bio Basic Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 JPT
        2.7.1 JPT Details
        2.7.2 JPT Major Business
        2.7.3 JPT Peptide CDMO Product and Services
        2.7.4 JPT Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Genscript
        2.8.1 Genscript Details
        2.8.2 Genscript Major Business
        2.8.3 Genscript Peptide CDMO Product and Services
        2.8.4 Genscript Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Xinbang Pharma
        2.9.1 Xinbang Pharma Details
        2.9.2 Xinbang Pharma Major Business
        2.9.3 Xinbang Pharma Peptide CDMO Product and Services
        2.9.4 Xinbang Pharma Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 ScinoPharm
        2.10.1 ScinoPharm Details
        2.10.2 ScinoPharm Major Business
        2.10.3 ScinoPharm Peptide CDMO Product and Services
        2.10.4 ScinoPharm Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 SN Biopharm
        2.11.1 SN Biopharm Details
        2.11.2 SN Biopharm Major Business
        2.11.3 SN Biopharm Peptide CDMO Product and Services
        2.11.4 SN Biopharm Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 CBL
        2.12.1 CBL Details
        2.12.2 CBL Major Business
        2.12.3 CBL Peptide CDMO Product and Services
        2.12.4 CBL Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Piramal Pharma
        2.13.1 Piramal Pharma Details
        2.13.2 Piramal Pharma Major Business
        2.13.3 Piramal Pharma Peptide CDMO Product and Services
        2.13.4 Piramal Pharma Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 CordenPharma
        2.14.1 CordenPharma Details
        2.14.2 CordenPharma Major Business
        2.14.3 CordenPharma Peptide CDMO Product and Services
        2.14.4 CordenPharma Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 CPC Scientific
        2.15.1 CPC Scientific Details
        2.15.2 CPC Scientific Major Business
        2.15.3 CPC Scientific Peptide CDMO Product and Services
        2.15.4 CPC Scientific Peptide CDMO Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Peptide CDMO Breakdown Data by Manufacturer
    3.1 Global Peptide CDMO Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Peptide CDMO Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Peptide CDMO
    3.4 Market Concentration Rate
        3.4.1 Top 3 Peptide CDMO Manufacturer Market Share in 2021
        3.4.2 Top 6 Peptide CDMO Manufacturer Market Share in 2021
    3.5 Global Peptide CDMO Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Peptide CDMO Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Peptide CDMO Market Size by Region
        4.1.1 Global Peptide CDMO Sales in Volume by Region (2017-2028)
        4.1.2 Global Peptide CDMO Revenue by Region (2017-2028)
    4.2 North America Peptide CDMO Revenue (2017-2028)
    4.3 Europe Peptide CDMO Revenue (2017-2028)
    4.4 Asia-Pacific Peptide CDMO Revenue (2017-2028)
    4.5 South America Peptide CDMO Revenue (2017-2028)
    4.6 Middle East and Africa Peptide CDMO Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Peptide CDMO Sales in Volume by Type (2017-2028)
    5.2 Global Peptide CDMO Revenue by Type (2017-2028)
    5.3 Global Peptide CDMO Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Peptide CDMO Sales in Volume by Application (2017-2028)
    6.2 Global Peptide CDMO Revenue by Application (2017-2028)
    6.3 Global Peptide CDMO Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Peptide CDMO Sales by Type (2017-2028)
    7.2 North America Peptide CDMO Sales by Application (2017-2028)
    7.3 North America Peptide CDMO Market Size by Country
        7.3.1 North America Peptide CDMO Sales in Volume by Country (2017-2028)
        7.3.2 North America Peptide CDMO Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Peptide CDMO Sales by Type (2017-2028)
    8.2 Europe Peptide CDMO Sales by Application (2017-2028)
    8.3 Europe Peptide CDMO Market Size by Country
        8.3.1 Europe Peptide CDMO Sales in Volume by Country (2017-2028)
        8.3.2 Europe Peptide CDMO Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Peptide CDMO Sales by Type (2017-2028)
    9.2 Asia-Pacific Peptide CDMO Sales by Application (2017-2028)
    9.3 Asia-Pacific Peptide CDMO Market Size by Region
        9.3.1 Asia-Pacific Peptide CDMO Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Peptide CDMO Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Peptide CDMO Sales by Type (2017-2028)
    10.2 South America Peptide CDMO Sales by Application (2017-2028)
    10.3 South America Peptide CDMO Market Size by Country
        10.3.1 South America Peptide CDMO Sales in Volume by Country (2017-2028)
        10.3.2 South America Peptide CDMO Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Peptide CDMO Sales by Type (2017-2028)
    11.2 Middle East & Africa Peptide CDMO Sales by Application (2017-2028)
    11.3 Middle East & Africa Peptide CDMO Market Size by Country
        11.3.1 Middle East & Africa Peptide CDMO Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Peptide CDMO Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Peptide CDMO and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Peptide CDMO
    12.3 Peptide CDMO Production Process
    12.4 Peptide CDMO Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Peptide CDMO Typical Distributors
    13.3 Peptide CDMO Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Peptide CDMO Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Peptide CDMO Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Bachem Basic Information, Manufacturing Base and Competitors
    Table 4. Bachem Major Business
    Table 5. Bachem Peptide CDMO Product and Services
    Table 6. Bachem Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. PolyPeptide Basic Information, Manufacturing Base and Competitors
    Table 8. PolyPeptide Major Business
    Table 9. PolyPeptide Peptide CDMO Product and Services
    Table 10. PolyPeptide Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. AmbioPharm Basic Information, Manufacturing Base and Competitors
    Table 12. AmbioPharm Major Business
    Table 13. AmbioPharm Peptide CDMO Product and Services
    Table 14. AmbioPharm Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. USV Peptides Basic Information, Manufacturing Base and Competitors
    Table 16. USV Peptides Major Business
    Table 17. USV Peptides Peptide CDMO Product and Services
    Table 18. USV Peptides Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Thermo Fisher Basic Information, Manufacturing Base and Competitors
    Table 20. Thermo Fisher Major Business
    Table 21. Thermo Fisher Peptide CDMO Product and Services
    Table 22. Thermo Fisher Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Bio Basic Basic Information, Manufacturing Base and Competitors
    Table 24. Bio Basic Major Business
    Table 25. Bio Basic Peptide CDMO Product and Services
    Table 26. Bio Basic Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. JPT Basic Information, Manufacturing Base and Competitors
    Table 28. JPT Major Business
    Table 29. JPT Peptide CDMO Product and Services
    Table 30. JPT Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Genscript Basic Information, Manufacturing Base and Competitors
    Table 32. Genscript Major Business
    Table 33. Genscript Peptide CDMO Product and Services
    Table 34. Genscript Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Xinbang Pharma Basic Information, Manufacturing Base and Competitors
    Table 36. Xinbang Pharma Major Business
    Table 37. Xinbang Pharma Peptide CDMO Product and Services
    Table 38. Xinbang Pharma Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. ScinoPharm Basic Information, Manufacturing Base and Competitors
    Table 40. ScinoPharm Major Business
    Table 41. ScinoPharm Peptide CDMO Product and Services
    Table 42. ScinoPharm Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 43. SN Biopharm Basic Information, Manufacturing Base and Competitors
    Table 44. SN Biopharm Major Business
    Table 45. SN Biopharm Peptide CDMO Product and Services
    Table 46. SN Biopharm Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 47. CBL Basic Information, Manufacturing Base and Competitors
    Table 48. CBL Major Business
    Table 49. CBL Peptide CDMO Product and Services
    Table 50. CBL Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 51. Piramal Pharma Basic Information, Manufacturing Base and Competitors
    Table 52. Piramal Pharma Major Business
    Table 53. Piramal Pharma Peptide CDMO Product and Services
    Table 54. Piramal Pharma Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 55. CordenPharma Basic Information, Manufacturing Base and Competitors
    Table 56. CordenPharma Major Business
    Table 57. CordenPharma Peptide CDMO Product and Services
    Table 58. CordenPharma Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 59. CPC Scientific Basic Information, Manufacturing Base and Competitors
    Table 60. CPC Scientific Major Business
    Table 61. CPC Scientific Peptide CDMO Product and Services
    Table 62. CPC Scientific Peptide CDMO Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 63. Global Peptide CDMO Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Tons)
    Table 64. Global Peptide CDMO Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 65. Market Position of Manufacturers in Peptide CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 66. Global Peptide CDMO Production Capacity by Company, (Tons): 2020 VS 2021
    Table 67. Head Office and Peptide CDMO Production Site of Key Manufacturer
    Table 68. Peptide CDMO New Entrant and Capacity Expansion Plans
    Table 69. Peptide CDMO Mergers & Acquisitions in the Past Five Years
    Table 70. Global Peptide CDMO Sales by Region (2017-2022) & (Tons)
    Table 71. Global Peptide CDMO Sales by Region (2023-2028) & (Tons)
    Table 72. Global Peptide CDMO Revenue by Region (2017-2022) & (USD Million)
    Table 73. Global Peptide CDMO Revenue by Region (2023-2028) & (USD Million)
    Table 74. Global Peptide CDMO Sales by Type (2017-2022) & (Tons)
    Table 75. Global Peptide CDMO Sales by Type (2023-2028) & (Tons)
    Table 76. Global Peptide CDMO Revenue by Type (2017-2022) & (USD Million)
    Table 77. Global Peptide CDMO Revenue by Type (2023-2028) & (USD Million)
    Table 78. Global Peptide CDMO Price by Type (2017-2022) & (US$/Ton)
    Table 79. Global Peptide CDMO Price by Type (2023-2028) & (US$/Ton)
    Table 80. Global Peptide CDMO Sales by Application (2017-2022) & (Tons)
    Table 81. Global Peptide CDMO Sales by Application (2023-2028) & (Tons)
    Table 82. Global Peptide CDMO Revenue by Application (2017-2022) & (USD Million)
    Table 83. Global Peptide CDMO Revenue by Application (2023-2028) & (USD Million)
    Table 84. Global Peptide CDMO Price by Application (2017-2022) & (US$/Ton)
    Table 85. Global Peptide CDMO Price by Application (2023-2028) & (US$/Ton)
    Table 86. North America Peptide CDMO Sales by Country (2017-2022) & (Tons)
    Table 87. North America Peptide CDMO Sales by Country (2023-2028) & (Tons)
    Table 88. North America Peptide CDMO Revenue by Country (2017-2022) & (USD Million)
    Table 89. North America Peptide CDMO Revenue by Country (2023-2028) & (USD Million)
    Table 90. North America Peptide CDMO Sales by Type (2017-2022) & (Tons)
    Table 91. North America Peptide CDMO Sales by Type (2023-2028) & (Tons)
    Table 92. North America Peptide CDMO Sales by Application (2017-2022) & (Tons)
    Table 93. North America Peptide CDMO Sales by Application (2023-2028) & (Tons)
    Table 94. Europe Peptide CDMO Sales by Country (2017-2022) & (Tons)
    Table 95. Europe Peptide CDMO Sales by Country (2023-2028) & (Tons)
    Table 96. Europe Peptide CDMO Revenue by Country (2017-2022) & (USD Million)
    Table 97. Europe Peptide CDMO Revenue by Country (2023-2028) & (USD Million)
    Table 98. Europe Peptide CDMO Sales by Type (2017-2022) & (Tons)
    Table 99. Europe Peptide CDMO Sales by Type (2023-2028) & (Tons)
    Table 100. Europe Peptide CDMO Sales by Application (2017-2022) & (Tons)
    Table 101. Europe Peptide CDMO Sales by Application (2023-2028) & (Tons)
    Table 102. Asia-Pacific Peptide CDMO Sales by Region (2017-2022) & (Tons)
    Table 103. Asia-Pacific Peptide CDMO Sales by Region (2023-2028) & (Tons)
    Table 104. Asia-Pacific Peptide CDMO Revenue by Region (2017-2022) & (USD Million)
    Table 105. Asia-Pacific Peptide CDMO Revenue by Region (2023-2028) & (USD Million)
    Table 106. Asia-Pacific Peptide CDMO Sales by Type (2017-2022) & (Tons)
    Table 107. Asia-Pacific Peptide CDMO Sales by Type (2023-2028) & (Tons)
    Table 108. Asia-Pacific Peptide CDMO Sales by Application (2017-2022) & (Tons)
    Table 109. Asia-Pacific Peptide CDMO Sales by Application (2023-2028) & (Tons)
    Table 110. South America Peptide CDMO Sales by Country (2017-2022) & (Tons)
    Table 111. South America Peptide CDMO Sales by Country (2023-2028) & (Tons)
    Table 112. South America Peptide CDMO Revenue by Country (2017-2022) & (USD Million)
    Table 113. South America Peptide CDMO Revenue by Country (2023-2028) & (USD Million)
    Table 114. South America Peptide CDMO Sales by Type (2017-2022) & (Tons)
    Table 115. South America Peptide CDMO Sales by Type (2023-2028) & (Tons)
    Table 116. South America Peptide CDMO Sales by Application (2017-2022) & (Tons)
    Table 117. South America Peptide CDMO Sales by Application (2023-2028) & (Tons)
    Table 118. Middle East & Africa Peptide CDMO Sales by Region (2017-2022) & (Tons)
    Table 119. Middle East & Africa Peptide CDMO Sales by Region (2023-2028) & (Tons)
    Table 120. Middle East & Africa Peptide CDMO Revenue by Region (2017-2022) & (USD Million)
    Table 121. Middle East & Africa Peptide CDMO Revenue by Region (2023-2028) & (USD Million)
    Table 122. Middle East & Africa Peptide CDMO Sales by Type (2017-2022) & (Tons)
    Table 123. Middle East & Africa Peptide CDMO Sales by Type (2023-2028) & (Tons)
    Table 124. Middle East & Africa Peptide CDMO Sales by Application (2017-2022) & (Tons)
    Table 125. Middle East & Africa Peptide CDMO Sales by Application (2023-2028) & (Tons)
    Table 126. Peptide CDMO Raw Material
    Table 127. Key Manufacturers of Peptide CDMO Raw Materials
    Table 128. Direct Channel Pros & Cons
    Table 129. Indirect Channel Pros & Cons
    Table 130. Peptide CDMO Typical Distributors
    Table 131. Peptide CDMO Typical Customers
List of Figures
    Figure 1. Peptide CDMO Picture
    Figure 2. Global Peptide CDMO Revenue Market Share by Type in 2021
    Figure 3. APIs and Intermediates
    Figure 4. FDF
    Figure 5. Global Peptide CDMO Revenue Market Share by Application in 2021
    Figure 6. Commercial
    Figure 7. Academic Research
    Figure 8. Global Peptide CDMO Revenue, (USD Million) & (Tons): 2017 & 2021 & 2028
    Figure 9. Global Peptide CDMO Revenue and Forecast (2017-2028) & (USD Million)
    Figure 10. Global Peptide CDMO Sales (2017-2028) & (Tons)
    Figure 11. Global Peptide CDMO Price (2017-2028) & (US$/Ton)
    Figure 12. Global Peptide CDMO Production Capacity (2017-2028) & (Tons)
    Figure 13. Global Peptide CDMO Production Capacity by Geographic Region: 2022 VS 2028
    Figure 14. Peptide CDMO Market Drivers
    Figure 15. Peptide CDMO Market Restraints
    Figure 16. Peptide CDMO Market Trends
    Figure 17. Global Peptide CDMO Sales Market Share by Manufacturer in 2021
    Figure 18. Global Peptide CDMO Revenue Market Share by Manufacturer in 2021
    Figure 19. Peptide CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 20. Top 3 Peptide CDMO Manufacturer (Revenue) Market Share in 2021
    Figure 21. Top 6 Peptide CDMO Manufacturer (Revenue) Market Share in 2021
    Figure 22. Global Peptide CDMO Sales Market Share by Region (2017-2028)
    Figure 23. Global Peptide CDMO Revenue Market Share by Region (2017-2028)
    Figure 24. North America Peptide CDMO Revenue (2017-2028) & (USD Million)
    Figure 25. Europe Peptide CDMO Revenue (2017-2028) & (USD Million)
    Figure 26. Asia-Pacific Peptide CDMO Revenue (2017-2028) & (USD Million)
    Figure 27. South America Peptide CDMO Revenue (2017-2028) & (USD Million)
    Figure 28. Middle East & Africa Peptide CDMO Revenue (2017-2028) & (USD Million)
    Figure 29. Global Peptide CDMO Sales Market Share by Type (2017-2028)
    Figure 30. Global Peptide CDMO Revenue Market Share by Type (2017-2028)
    Figure 31. Global Peptide CDMO Price by Type (2017-2028) & (US$/Ton)
    Figure 32. Global Peptide CDMO Sales Market Share by Application (2017-2028)
    Figure 33. Global Peptide CDMO Revenue Market Share by Application (2017-2028)
    Figure 34. Global Peptide CDMO Price by Application (2017-2028) & (US$/Ton)
    Figure 35. North America Peptide CDMO Sales Market Share by Type (2017-2028)
    Figure 36. North America Peptide CDMO Sales Market Share by Application (2017-2028)
    Figure 37. North America Peptide CDMO Sales Market Share by Country (2017-2028)
    Figure 38. North America Peptide CDMO Revenue Market Share by Country (2017-2028)
    Figure 39. United States Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 40. Canada Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 41. Mexico Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Europe Peptide CDMO Sales Market Share by Type (2017-2028)
    Figure 43. Europe Peptide CDMO Sales Market Share by Application (2017-2028)
    Figure 44. Europe Peptide CDMO Sales Market Share by Country (2017-2028)
    Figure 45. Europe Peptide CDMO Revenue Market Share by Country (2017-2028)
    Figure 46. Germany Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 47. France Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. United Kingdom Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. Russia Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Italy Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Asia-Pacific Peptide CDMO Sales Market Share by Region (2017-2028)
    Figure 52. Asia-Pacific Peptide CDMO Sales Market Share by Application (2017-2028)
    Figure 53. Asia-Pacific Peptide CDMO Sales Market Share by Region (2017-2028)
    Figure 54. Asia-Pacific Peptide CDMO Revenue Market Share by Region (2017-2028)
    Figure 55. China Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. Japan Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Korea Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. India Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Southeast Asia Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Australia Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. South America Peptide CDMO Sales Market Share by Type (2017-2028)
    Figure 62. South America Peptide CDMO Sales Market Share by Application (2017-2028)
    Figure 63. South America Peptide CDMO Sales Market Share by Country (2017-2028)
    Figure 64. South America Peptide CDMO Revenue Market Share by Country (2017-2028)
    Figure 65. Brazil Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. Argentina Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Middle East & Africa Peptide CDMO Sales Market Share by Type (2017-2028)
    Figure 68. Middle East & Africa Peptide CDMO Sales Market Share by Application (2017-2028)
    Figure 69. Middle East & Africa Peptide CDMO Sales Market Share by Region (2017-2028)
    Figure 70. Middle East & Africa Peptide CDMO Revenue Market Share by Region (2017-2028)
    Figure 71. Turkey Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 72. Egypt Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Saudi Arabia Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. South Africa Peptide CDMO Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Manufacturing Cost Structure Analysis of Peptide CDMO in 2021
    Figure 76. Manufacturing Process Analysis of Peptide CDMO
    Figure 77. Peptide CDMO Industrial Chain
    Figure 78. Sales Channel: Direct Channel vs Indirect Channel
    Figure 79. Methodology
    Figure 80. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bachem
PolyPeptide
AmbioPharm
USV Peptides
Thermo Fisher
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CordenPharma
CPC Scientific

Related Reports

Global Peptide CDMO Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Peptide CDMO Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 30 Jun 2021

date Medical Care

The Peptide CDMO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Peptide CDMO Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Peptide CDMO Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 17 Jan 2022

date Medical Care

Global Peptide CDMO Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Peptide CDMO Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.

Global Peptide CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Peptide CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 26 Apr 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Peptide CDMO market size was valued at USD 3265.7 million in 2022 and is forecast to a readjusted size of USD 8327.1 million by 2029 with a CAGR of 14.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Peptide CDMO Supply, Demand and Key Producers, 2023-2029

Global Peptide CDMO Supply, Demand and Key Producers, 2023-2029

date 26 Apr 2023

date Pharma & Healthcare

The global Peptide CDMO market size is expected to reach $ 8327.1 million by 2029, rising at a market growth of 14.3% CAGR during the forecast period (2023-2029).

Global Peptide CDMO Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Peptide CDMO Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Peptide CDMO market size was valued at USD 3265.7 million in 2023 and is forecast to a readjusted size of USD 8327.1 million by 2030 with a CAGR of 14.3% during review period.

Product Tags

peptide cdmo

Peptide CDMO Pharmaceutical

Peptide CDMO Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>